These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19778161)

  • 61. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems.
    Cirri M; Mura P; Mora PC
    Int J Pharm; 2007 Aug; 340(1-2):84-91. PubMed ID: 17531411
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin.
    Hintzen F; Perera G; Hauptstein S; Müller C; Laffleur F; Bernkop-Schnürch A
    Int J Pharm; 2014 Sep; 472(1-2):20-6. PubMed ID: 24879935
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Design and evaluation of a self-microemulsifying drug delivery system for apigenin.
    Zhao L; Zhang L; Meng L; Wang J; Zhai G
    Drug Dev Ind Pharm; 2013 May; 39(5):662-9. PubMed ID: 22607130
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Practical use of o,p'DDD in adrenocortical carcinoma].
    Bacchetta J; Droz JP
    Bull Cancer; 2005 Mar; 92(3):273-9. PubMed ID: 15820922
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Development and oral bioavailability assessment of a supersaturated self-microemulsifying drug delivery system (SMEDDS) of albendazole.
    Mukherjee T; Plakogiannis FM
    J Pharm Pharmacol; 2010 Sep; 62(9):1112-20. PubMed ID: 20796189
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Formulation design and evaluation of a self-microemulsifying drug delivery system of lovastatin.
    Goyal U; Arora R; Aggarwal G
    Acta Pharm; 2012 Nov; 62(3):357-70. PubMed ID: 23470348
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Preparation of the oral self-microemulsifying drug delivery system of GBE50].
    Xiong Y; Liu QD; Lai L; Chen JH
    Yao Xue Xue Bao; 2009 Jul; 44(7):803-8. PubMed ID: 19806924
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intestinal permeability studies of sulpiride incorporated into self-microemulsifying drug delivery system (SMEDDS).
    Chitneni M; Peh KK; Darwis D; Abdulkarim M; Abdullah GZ; Qureshi MJ
    Pak J Pharm Sci; 2011 Apr; 24(2):113-21. PubMed ID: 21454158
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Study of cosurfactant effect on nanoemulsifying area and development of lercanidipine loaded (SNEDDS) self nanoemulsifying drug delivery system.
    Parmar N; Singla N; Amin S; Kohli K
    Colloids Surf B Biointerfaces; 2011 Sep; 86(2):327-38. PubMed ID: 21550214
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Enhancement of dissolution rate of mitotane and warfarin prepared by using microemulsion systems.
    Lin YH; Chen YS; Wu TC; Chen LJ
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):366-72. PubMed ID: 21478000
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacokinetics of the adrenocorticolytic compounds 3-methylsulphonyl-DDE and o,p'-DDD (mitotane) in Minipigs.
    Hermansson V; Cantillana T; Hovander L; Bergman A; Ljungvall K; Magnusson U; Törneke K; Brandt I
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):267-74. PubMed ID: 17431626
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [In vitro and in vivo evaluation of total flavones of Hippophae rhamnoides self-microemulsifying drug delivery system].
    Li GL; Fan YT; Zhang YH; Li YF; Li XR; Liu Y; Li M
    Yao Xue Xue Bao; 2012 Aug; 47(8):1055-62. PubMed ID: 23162904
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In situ intestinal permeability and in vivo absorption characteristics of olmesartan medoxomil in self-microemulsifying drug delivery system.
    Kang MJ; Kim HS; Jeon HS; Park JH; Lee BS; Ahn BK; Moon KY; Choi YW
    Drug Dev Ind Pharm; 2012 May; 38(5):587-96. PubMed ID: 21988221
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oral bioavailability enhancement of exemestane from self-microemulsifying drug delivery system (SMEDDS).
    Singh AK; Chaurasiya A; Awasthi A; Mishra G; Asati D; Khar RK; Mukherjee R
    AAPS PharmSciTech; 2009; 10(3):906-16. PubMed ID: 19609837
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe.
    Bali V; Ali M; Ali J
    Colloids Surf B Biointerfaces; 2010 Apr; 76(2):410-20. PubMed ID: 20042320
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Assessment of Pueraria lobata isoflavone with self-microemulsifying drug delivery systems in vitro and in vivo].
    Cui SM; Zhao CS; He ZG
    Zhong Yao Cai; 2007 Jun; 30(6):684-7. PubMed ID: 17918441
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preparation and in vitro performance evaluation of resveratrol for oral self-microemulsion.
    Tang H; Xiang S; Li X; Zhou J; Kuang C
    PLoS One; 2019; 14(4):e0214544. PubMed ID: 30990813
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lack of long-lasting effects of mitotane adjuvant therapy in a mouse xenograft model of adrenocortical carcinoma.
    Doghman M; Lalli E
    Mol Cell Endocrinol; 2013 Dec; 381(1-2):66-9. PubMed ID: 23906534
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Formulation and In Vitro Evaluation of Self Microemulsifying Drug Delivery System Containing Atorvastatin Calcium.
    Diril M; Türkyılmaz GY; Karasulu HY
    Curr Drug Deliv; 2019; 16(8):768-779. PubMed ID: 31429689
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development of a pharmacokinetic model of mitotane: toward personalized dosing in adrenocortical carcinoma.
    Kerkhofs TM; Derijks LJ; Ettaieb H; den Hartigh J; Neef K; Gelderblom H; Guchelaar HJ; Haak HR
    Ther Drug Monit; 2015 Feb; 37(1):58-65. PubMed ID: 24887633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.